| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908094 | Experimental Hematology | 2005 | 12 Pages |
Abstract
These data indicate that PS-341 can sensitize myeloma cells to IR by both intrinsic and extrinsic apoptotic pathways. The study indicates improved therapeutic benefits in treatment of multiple myeloma by combining PS-341 with conventional radiotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Apollina Goel, Angela Dispenzieri, Philip R. Greipp, Thomas E. Witzig, Ruben A. Mesa, Stephen J. Russell,